Rational phytotechnologies methods have been used to obtain a number of medicinal preparations from a natural national plant resource Glycyrrhize Glabra, which approved regulatory documents in the form of patents and technological regulations. The firstly in the practice of world medical science, saponin-containing preparations of licorice naked were identified, allowing them to be widely used in medical practice for the treatment of oncological diseases, as well as diseases accompanied by a decrease in the Immune system. The scientific article presents the results of pharmaceutical and toxicopharmacological studies of medicinal preparations of the medicinal plant Glycyrrhiza glabra seu Licorice. For the first time in the practice of world medical science, the lymphotropic properties of saponin-containing licorice compounds, obtained in the form of dry and dense aqueous extracts, as well as in the form of therapeutic syrups, have been identified and substantiated. Toxicological experiments proved their low toxicity and safety. On the basis of the obtained dense and dry aqueous extracts of Glycyrrhiza glabra, a number of drugs and medicinal biologically active additives were developed for the first time and received certificates in the form of National and Eurasian Patents. It has been shown that the developed therapeutic agents have anti-inflammatory, immunostimulating, antitussive, antihemorrhoidal, cardiotonic, antiviral, sedative, diuretic, antitumor activities, which allows them to be recommended for widespread medical use. Developed licorice-based medicinal syrups: “Licorice syrup”, “Licorice of Immunovit”, “Licorice Hem”, “Licorice Cardio”, “Licorice Broncho”, “Licorice Qripson”, “Licorice Uro”, “Licorice Sed” are produced by the national industry “Biyan Products LTD” and have been highly praised by buyers.
Keywords: Licorice, preparations, patent
14-19 | 133 View | 17 Download